Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

Diabetes/Metabolism Research and Reviews

Volumn 17, Issue 6, 2001, Pages 467-473

  Holstein, Andreas ^a   Plaschke, Armin ^a   Egberts, Eick Hartwig ^a  

^a KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Glibenclamide; Glimepiride; Hypoglycaemia; Sulphonylureas; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; GLUCAGON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GERMANY; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; PROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS;

EID: 0035667081     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.235     Document Type: Article

References (26)

1. Antidiabetika
2. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at β-cells
3. Clinical profile of the novel sulphonylurea glimepiride
4. Rates of hypoglycaemia in users of sulfonylureas
5. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas
6. Hypoglykämische Stoffwechselentgleisungen bei medikamentös behandelten Typ-II-Diabetikern
7. Medikamentös bedingte Hypoglykämien bei Type-II-Diabetes
8. Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus
9. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide
10. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study
11. Glibenclamide-associated hypoglycaemia: A report on 57 cases
12. Schätzung der Diabeteshäufigkeit in der Bundesrepublik Deutschland anhand von Krankenkassendaten
13. Die Prävalenz des Diabetes mellitus wird in Deutschland deutlich unterschätzteine bundesweite epidemiologische Studie auf der Basis einer HbA1c- Analyse
14. Epidemiology of severe hypoglycaemia in the Diabetic Control and Complication Trial
15. Practicality and accuracy of rapid venous blood glucose determination in pre-hospital emergency medicine
16. Prediction of creatinine clearance from serum creatinine
17. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
18. Population-based adherence to prescribed medication in Type 2 diabetes: A cause for concern
19. Differential interaction of glimepiride and glibenclamide with the β-cell-sulfonylurea receptor. I. Binding characteristics
20. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man
21. Extrapancreatic effects of sulfonylureas - A comparison between glimepiride and conventional sulfonylureas
22. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide
23. Pharmacokinetics and safety of glimepiride at clinically doses in diabetic patients with renal impairment
24. The elderly Type 2 diabetic patient: Special considerations
25. The use of sulphonylureas in the elderly
26. Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission